For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Zhigan Jiang

USPTO Granted Patents = 17 (Patent Applications = 11)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 22)

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

Medshine Discovery Inc.

Shandong Danhong Pharmaceutical Co., Ltd.

Guangdong Raynovent Biotech Co., Ltd.

Heilongjiang Zhenbaodao Pharmaceutical Co, Ltd

Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.

Fujian Cosunter Pharmaceutical Co., Ltd.

Fujian Akeylink Biotechnology Co., Ltd.

Phaeno Therapeutics Co., Ltd.

9. 1 out of 3,923

where one patent can have more than one assignee

Years Active: 2017-2024

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11964969 - Crystal forms of thiazole compound and application thereof (2024-04-23),

2. 11952388 - Crystal form of tri-cycle compound and application thereof (2024-04-09),

3. 11680070 - Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof (2023-06-20),

4. 11673899 - Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof (2023-06-13),

5. 11578081 - Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof (2023-02-14),

6. 11396493 - Amorphous pyrrolidine derivative as PPAR agonist and preparation method thereof (2022-07-26),

7. 11299482 - Salt and crystal form of modified andrographolide compound and preparation method thereof (2022-04-12),

8. 11053260 - Tri-cycle compound and applications thereof (2021-07-06),

9. 10858322 - Process for preparing 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2020-12-08),

10. 10717720 - Modified compound of andrographolide (2020-07-21),

11. 10647710 - Thiazole derivative and applications thereof (2020-05-12),

12. 10633347 - Crystal form B of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2020-04-28),

13. 10526320 - Pyrrolidine derivatives as PPAR agonists (2020-01-07),

14. 10227309 - Crystal form A of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2019-03-12),

15. 10160726 - Quinolone derivatives as antibacterials (2018-12-25),

Title: Unveiling the Innovations of Inventor Zhigan Jiang from Shanghai

Introduction:

Zhigan Jiang, a prolific inventor hailing from the bustling city of Shanghai, CN, has made significant contributions to the field of pharmaceuticals with a remarkable total of 17 patents to his name. His groundbreaking inventions have revolutionized the treatment of various diseases, particularly those associated with the herpes simplex virus and HBV-related conditions.

Latest Patents:

1. Crystal forms of thiazole compound and application thereof: Jiang's latest patent unveils crystal form A of a compound represented by formula (I), a compound represented by formula (II), and crystal form B, showcasing their potential application in developing drugs for diseases linked to the herpes simplex virus.

2. Crystal form of tri-cycle compound and application thereof: Another innovative patent by Jiang features crystal forms A and B of a compound described by formula (I), illustrating their utilization in creating medications for HBV-related illnesses.

Career Highlights:

Throughout his career, Jiang has honed his expertise in the pharmaceutical sector through pivotal roles at renowned companies such as Medshine Discovery Inc. and Shandong Danhong Pharmaceutical Co., Ltd. His innovative spirit and dedication to advancing healthcare have led to the successful development and patenting of numerous novel technologies.

Collaborations:

Jiang's impactful work would not have been possible without the collaboration of esteemed colleagues like Haiying He and Shuhui Chen. Together, they have synergized their talents to drive forward cutting-edge research initiatives and bring revolutionary inventions to fruition.

Conclusion:

Inventor Zhigan Jiang stands as a beacon of innovation in the realm of pharmaceuticals, with his trailblazing patents paving the way for novel treatment approaches in combating various diseases. His collaborations and career milestones underscore his unwavering commitment to advancing healthcare through inventive solutions, making him a true visionary in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…